Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67


Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species.

Lange S, Heger J, Euler G, Wartenberg M, Piper HM, Sauer H.

Cardiovasc Res. 2009 Jan 1;81(1):159-68. doi: 10.1093/cvr/cvn258. Epub 2008 Sep 20.


Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells.

Hwang KY, Oh YT, Yoon H, Lee J, Kim H, Choe W, Kang I.

Neurosci Lett. 2008 Oct 31;444(3):264-9. doi: 10.1016/j.neulet.2008.08.057. Epub 2008 Aug 27.


Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells.

Gurusamy N, Mukherjee S, Lekli I, Bearzi C, Bardelli S, Das DK.

Antioxid Redox Signal. 2009 Mar;11(3):589-600. doi: 10.1089/ARS.2008.2195.


Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1.

Milovanova TN, Bhopale VM, Sorokina EM, Moore JS, Hunt TK, Hauer-Jensen M, Velazquez OC, Thom SR.

Mol Cell Biol. 2008 Oct;28(20):6248-61. doi: 10.1128/MCB.00795-08. Epub 2008 Aug 18.


Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia.

Urao N, Inomata H, Razvi M, Kim HW, Wary K, McKinney R, Fukai T, Ushio-Fukai M.

Circ Res. 2008 Jul 18;103(2):212-20. doi: 10.1161/CIRCRESAHA.108.176230. Epub 2008 Jun 26.


Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up.

Clarke RE, Tenorio LM, Hussey JR, Toklu AS, Cone DL, Hinojosa JG, Desai SP, Dominguez Parra L, Rodrigues SD, Long RJ, Walker MB.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):134-143. doi: 10.1016/j.ijrobp.2007.12.048. Epub 2008 Mar 14.


Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation.

Watson WH, Heilman JM, Hughes LL, Spielberger JC.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):832-6. doi: 10.1016/j.bbrc.2008.02.006. Epub 2008 Feb 11.


The role of hypoxia-inducible factors in tumorigenesis.

Rankin EB, Giaccia AJ.

Cell Death Differ. 2008 Apr;15(4):678-85. doi: 10.1038/cdd.2008.21. Epub 2008 Feb 15. Review.


Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions.

Maulik N, Das DK.

Biochim Biophys Acta. 2008 Nov;1780(11):1368-82. doi: 10.1016/j.bbagen.2007.12.008. Epub 2008 Jan 16. Review. Erratum in: Biochim Biophys Acta. 2010 Sep;1800(9):1027.


Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase.

Mofarrahi M, Brandes RP, Gorlach A, Hanze J, Terada LS, Quinn MT, Mayaki D, Petrof B, Hussain SN.

Antioxid Redox Signal. 2008 Mar;10(3):559-74.


Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression.

Maynard MA, Evans AJ, Shi W, Kim WY, Liu FF, Ohh M.

Cell Cycle. 2007 Nov 15;6(22):2810-6. Epub 2007 Aug 29.


Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.

Pagé EL, Chan DA, Giaccia AJ, Levine M, Richard DE.

Mol Biol Cell. 2008 Jan;19(1):86-94. Epub 2007 Oct 17.


Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.

Circulation. 2007 Jul 10;116(2):163-73. Epub 2007 Jun 25.


The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions.

Piccoli C, D'Aprile A, Ripoli M, Scrima R, Boffoli D, Tabilio A, Capitanio N.

FEBS Lett. 2007 Jun 26;581(16):3111-9. Epub 2007 Jun 6.


Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC.

J Clin Invest. 2007 May;117(5):1249-59.


Guidelines for the treatment of arterial insufficiency ulcers.

Hopf HW, Ueno C, Aslam R, Burnand K, Fife C, Grant L, Holloway A, Iafrati MD, Mani R, Misare B, Rosen N, Shapshak D, Benjamin Slade J Jr, West J, Barbul A.

Wound Repair Regen. 2006 Nov-Dec;14(6):693-710. No abstract available.


Endothelial cell response to lactate: implication of PAR modification of VEGF.

Kumar VB, Viji RI, Kiran MS, Sudhakaran PR.

J Cell Physiol. 2007 May;211(2):477-85.


Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.

Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, Simon MC.

Mol Cell Biol. 2007 Feb;27(3):912-25. Epub 2006 Nov 13.


Nitric oxide induces thioredoxin-1 nuclear translocation: possible association with the p21Ras survival pathway.

Arai RJ, Masutani H, Yodoi J, Debbas V, Laurindo FR, Stern A, Monteiro HP.

Biochem Biophys Res Commun. 2006 Oct 6;348(4):1254-60. Epub 2006 Aug 7.


Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide.

Goldstein LJ, Gallagher KA, Bauer SM, Bauer RJ, Baireddy V, Liu ZJ, Buerk DG, Thom SR, Velazquez OC.

Stem Cells. 2006 Oct;24(10):2309-18. Epub 2006 Jun 22.

Supplemental Content

Support Center